We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

vrijdag 15 september 2017

The Lancet: [Comment] Africa and health: a Commission to accelerate success

[Comment] Africa and health: a Commission to accelerate success
The final results of a 4-year project to analyse the challenges and opportunities for health in sub-Saharan Africa are now published as a Lancet Commission—The Path to Longer and Healthier Lives for All Africans by 2030—led by African physicians, health scientists, and policy makers.1 Their conclusion is one of qualified optimism, grounded in a rigorous appraisal of new evidence and past experience. The vision of the Commission is that Africans should expect the same opportunities for health by 2030 as all other peoples.
Read more

[Comment] Longer and healthier lives for all Africans by 2030: perspectives and action of WHO AFRO
The Path to Longer and Healthier Lives for All Africans by 2030: the Lancet Commission on the Future of Health in sub-Saharan Africa1 is of great interest to the WHO Regional Office for Africa (WHO AFRO). This Commission by Irene Agyepong and colleagues expresses its conviction that a health system ensuring positive health outcomes for everyone, irrespective of socioeconomic class, gender, religion, or location, is possible and realisable in the African Region, despite many challenges. It identifies immense opportunities, which will foster health development if acted upon without delay.
Read more

[Perspectives] Irene Agyepong: building capacity in Ghana's public health system
As a lead author of the Lancet Commission on the future of health in sub-Saharan Africa, Irene Agyepong's ambition is to make a lasting contribution to health in Africa. "One of my driving passions is building health policy and systems research, policy, and practice capacity in west Africa. To conduct research, to advance research evidence and decision making, and ultimately to improve outcomes", she says. "I am really interested in transformation and health outcomes, and human development in sub-Saharan Africa.
Read more

[Department of Error] Department of Error
Woodcock A, Vestbo J, Bakerly ND, et al. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial. Lancet 2017; published online Sept 10. http://dx.doi.org/10.1016/S0140-6736(17)32397-8—In table 1 of this Article (published Online First on Sept 10, 2017), the number of patients in the fluticasone furoate and vilanterol group who did not have any exacerbations in the previous year before randomisation should be 1378.
Read more

[Articles] Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Use of CGM during pregnancy in patients with type 1 diabetes is associated with improved neonatal outcomes, which are likely to be attributed to reduced exposure to maternal hyperglycaemia. CGM should be offered to all pregnant women with type 1 diabetes using intensive insulin therapy. This study is the first to indicate potential for improvements in non-glycaemic health outcomes from CGM use.
Read more